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Abstract
Background: The calsarcins comprise a novel family of muscle-specific calcineurin-interaction
proteins that play an important role in modulating both the function and substrate specificity of
calcineurin in muscle cells. The expression of calsarcin-1 (CS-1) is restricted to slow-twitch skeletal
muscle fibres, whereas that of both calsarcin-2 (CS-2) and calsarcin-3 (CS-3) is enriched in fast-
twitch fibres. However, the transcriptional control of this selective expression has not been
previously elucidated.
Results: Our real-time RT-PCR analyses suggest that the expression of CS-1 and CS-2 is increased
during the myogenic differentiation of mouse C2C12 cells. Promoter deletion analysis further
suggests that an NF-κB binding site within the CS-1 promoter is responsible for the up-regulation
of CS-1 transcription, but no similar mechanism was evident for CS-2. These findings are further
supported by the results of EMSA analysis, as well as by overexpression and inhibition experiments
in which NF-κB function was blocked by treatment with its inhibitor, PDTC. In addition, the
overexpression of NFATc4 induces both the CS-1 and CS-2 promoters, whereas MEF2C only
activates CS-1.
Conclusion: Our present data suggest that NF-κB is required for the transcription of mouse CS-
1 but not CS-2, and that the regulation of the calsarcins is mediated also by the NFAT and MEF2
transcription factors. These results provide new insights into the molecular mechanisms governing
transcription in specific muscle fibre cells. The calsarcins may also serve as a valuable mechanistic
tool to better understand the regulation of calcineurin signalling during muscle differentiation.
Background
Calcineurin, a calcium/calmodulin-dependent serine
threonine phosphatase, is an important signalling mole-
cule in skeletal muscle, as it promotes differentiation, the
slow-fibre phenotype, and possibly also fibre hypertro-
phy. Calcineurin binds to the calsarcins, a family of mus-
cle proteins that are specific to the sarcomeric Z-disc,
which is a focal point in the regulation of contraction
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both in skeletal and cardiac muscle. Calsarcin-1, -2 and -3
all interact with calcineurin and the Z-disc proteins α-
actinin,  γ-filamin, myotilin, telethonin and cipher [1].
Several groups have independently identified the calsarcin
family and termed it calsarcin [2], FATZ [3], myozenin [4],
and c4orf5 [5], in separate reports. The calsarcins may also
have a structural role in Z-disc assembly via their ability to
bind different Z-disc proteins, as well as a possible
involvement in signalling pathways that are activated via
their binding to calcineurin.
CS-1 is the only member of the calsarcin family that is
expressed in the adult heart and in slow-twitch skeletal
muscle, whereas CS-2 and CS-3 are expressed in fast-
twitch muscle [2,6,7]. Several studies have also shown
that calcineurin controls the skeletal muscle fibre type by
stimulating slow muscle gene promoters and slow fibre
differentiation both in cultured cells and in vivo [8,9]. In
addition, CS-1 knockout mice show enhanced calcineurin
signalling and an excess of slow skeletal muscle fibres,
indicating that CS-1 negatively modulates the function of
calcineurin [10]. Given that both the functions and sub-
strate specificity of calcineurin are modulated by the cal-
sarcins, and that calcineurin operates in the signalling
pathways that control the muscle fibre type, a mechanism
of muscle fibre determination and differentiation that is
regulated by the interactions between calcineurin and the
calsarcins can possibly be hypothesized. However,
whether the fibre type-specific expression of calsarcins is
also controlled by calcineurin remains to be determined.
In our current study, we have investigated the molecular
mechanisms underlying the transcriptional regulation of
the mouse CS-1 and CS-2 genes, with a particular focus on
the promoter sequences of these genes as they are respon-
sive to calcineurin signalling.
Results
Determination of transcription start sites (TSS) for mouse 
CS-1 and CS-2
To further characterize the transcriptional control of the
mouse CS-1 and CS-2  genes, we first determined their
respective transcription start sites. RT-PCR analysis was
performed using total RNA extracts of C2C12 cells and
four different forward primers and one reverse primer for
each gene. As shown in Table 1, the reverse primer is
located in exon 1 and the different forward primers are
located around the putative transcription start sites. The
results of these analyses show that the first three primer
pairs of CS-1, and first two for CS-2, successfully yielded
PCR products. This indicates that the sequences contained
within these oligonucleotides form part of the mRNA
product of each gene (Fig. 1). We concluded that the TSS
sites of mouse CS-1 and CS-2 are located at -191 to -176
and -82 to -74, respectively. The nucleotide immediately
upstream of the translation initiation codon (ATG) is
denoted as -1.
Transcriptional regulation of CS-1 and CS-2 during 
myogenic differentiation
Real-time PCR analysis was performed to determine the
relative mRNA expression levels of both the mouse CS-1
and CS-2 genes during myoblast differentiation in C2C12
cells. Specific primers corresponding to the two genes
were designed and the housekeeping gene β-actin  was
used as a control. We subsequently found that the CS-1
and CS-2 transcript levels were both low at the myoblast
stage. CS-1 mRNA expression increases markedly, how-
ever, during the first two days of differentiation and is
then maintained at relatively abundant levels throughout
this process. In contrast, the CS-2 transcript levels remain
low throughout myogenic differentiation (Fig. 2).
Promoter analysis of the mouse CS-1 and CS-2 gene
To test the minimal region required for promoter activity
within the upstream CS-1 and CS-2 sequences, fragments
corresponding to the regions -2554 to -144 of CS-1 and -
2478 to -67 of CS-2 (relative to the ATG initiation codon),
were inserted into the pGL3-basic vector and luciferase
assays were performed. A significant increase in luciferase
activity was observed in the C2C12 cell line (almost 20-
fold and 16-fold increases following transfection with the
promoter-luciferase vectors pCS1-2554/-144 and pCS2-
2478/-67, respectively) compared with cells transfected
with the empty vector (Fig. 3). Sequence analysis of these
two promoter segments revealed that the flanking region
harbours potential binding sites for multiple transcription
factors including Sp1 and AP-1, in addition to the muscle
specific transcription factors MEF-2 and MyoD. However,
no TATA-boxes are present in these regions.
Identification of the transcription start site for the mouse  CS1 and CS2 genes by RT-PCR Figure 1
Identification of the transcription start site for the 
mouse CS1 and CS2 genes by RT-PCR. Four different 
forward primers and a common reverse primer were used 
for each gene as shown in Table 1. Lanes 1–8 indicate the 
results of RT-PCR using the forward primers CS1RT1L, 
CS1RT2L, CS1RT3L, CS1RT4L, CS2RT1L, CS2RT2L, 
CS2RT3L, CS2RT4L, and the corresponding reverse primers 
CS1RTR and CS2RTR, respectively.BMC Molecular Biology 2007, 8:19 http://www.biomedcentral.com/1471-2199/8/19
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We next generated a series of deletion mutants for the CS-
1 and CS-2 promoters via PCR-based approaches using
the pCS1-2554/-144 and pCS2-2478/-67 constructs as
templates. The amplified mutant fragments were then
subcloned into the pGL3-basic vector and our results are
shown in Figure 3. For the CS-1 promoter fragments, the
deletion constructs pCS1-1954/-144 and pCS1-1206/-
144 display high promoter activity. Further deletions at
positions -926 (pCS1-926/-144) and -554 (pCS1-554/-
144) resulted in a gradual decrease in promoter activity.
However, the highest promoter activity levels were
observed for the pCS1-427/-144 construct, suggesting that
there are inhibitory elements within the region -554 to -
427. Deletions at positions -337(pCS1-337/-144) and -
244(pCS1-244/-144) also reduce promoter activity dra-
matically, whereas the pCS1-199/-144 construct shows
almost no luciferase activity (Fig. 3A). Taken together,
these reporter data indicate that the core region of the
basal promoter of mouse CS-1 gene is located within the
region -427 to -337. For the CS-2 promoter, the deletion
constructs pCS2-1859/-67, pCS2-1166/-67 and pCS2-
561/-67 display high promoter activity with only modest
differences between them, suggesting that each harbours
the core elements necessary for the basal promoter func-
tion of the mouse CS-2 gene. The promoter activity of
pCS2-482/-67, PCS2-333/-67 and pCS2-185/-67
decreases gradually to relatively low levels and thus fur-
ther defines the core region from -561 to -185 (Fig. 3B).
For our initial characterization of these two promoters, we
searched for the presence of a consensus slow upstream
regulatory element (SURE) and fast intronic regulatory
element (FIRE), which have been shown to drive fibre-
specific gene transcription [8]. However, neither of these
sites was found to be present in the two respective pro-
moter regions after careful analysis using TESS software.
We then focused on the association of other transcription
factors with the two gene promoters, such as the role of
calcineurin signalling factors in activating the slow-fibre
specific promoter of CS-1. It was noticeable that the pCS1-
Real-time PCR analysis of CS1 and CS2 mRNA expression during the myogenic differentiation of C2C12 cells (day 0 to day 7) Figure 2
Real-time PCR analysis of CS1 and CS 2 mRNA expression during the myogenic differentiation of C2C12 cells 
(day 0 to day 7). Values are expressed as ratios of the basal transcription levels on culture day 0 for CS2.BMC Molecular Biology 2007, 8:19 http://www.biomedcentral.com/1471-2199/8/19
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427/-144 construct exhibited maximum activity and that
deletion of the region -427 to -337 of CS-1 5' flanking
sequence reduced the promoter activity dramatically,
indicating that a strongly positive element is located in
this region. A putative binding site for the NF-κB tran-
scription factor was detectable in this region using high-
stringency analysis of the TESS database. However, a puta-
tive binding site for NF-κB was also assigned to the core
region of CS-2  promoter in these searches. Since our
reporter assay findings raised the possibility that transac-
tivation of the mouse CS-1  and  CS-2  gene may be
achieved through NF-κB binding elements present in their
core promoters, we attempted to determine which of
Reporter analysis of the mouse CS1 and CS2 gene promoters Figure 3
Reporter analysis of the mouse CS1 and CS2 gene promoters. A. Reporter analysis of mouse CS1 gene promoter dele-
tion constructs. B. Reporter analysis of mouse CS2 gene promoter deletion constructs. The 5'-deleted promoter segments 
were generated as described in Materials and Methods. C2C12 cells were co-transfected with various promoter regions fused 
to firefly luciferase and with a Renilla luciferase expression control vector. The resulting firefly luciferase activity was then nor-
malized to Renilla luciferase activity and the relative values are presented as the fold-increase over the activity of the promot-
erless pGL3-basic vector. The length of each 5'-deletion fragment is calculated relative to the translation initiation ATG codon 
and is indicated to the left of each bar. The presence of putative NF-κB binding elements is also indicated. Values represent the 
mean ± SD of three independent experiments.BMC Molecular Biology 2007, 8:19 http://www.biomedcentral.com/1471-2199/8/19
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these two potential NF-κB binding sites was authentic
during this activation event.
Confirmation of NF-κB binding to the CS-1 promoter by 
EMSA
We synthesized specific oligonucleotides containing the
NF-κB elements present in the CS-1 and CS-2 promoters
and tested them with an NF-κB consensus sequence con-
trol in EMSA experiments with nuclear extracts from
C2C12 myotubes. As shown in Figure 4A, incubation of
C2C12 nuclear extracts with both the NF-κB consensus
sequence and NF-κB-CS1 sequence produced a DNA-pro-
tein band shift. In contrast, the NF-κB-CS2 oligonucle-
otide probe failed to form such a complex in this
experiment. These DNA-protein complexes were deter-
mined to be specific to the NF-κB sites by successful com-
petition assays using excess unlabeled consensus and NF-
κB-CS1 oligonucleotides (Fig. 4B). To confirm the bind-
ing of NF-κB family members to the NF-κB-CS1 sequence,
these EMSA reactions were further incubated with anti-
bodies raised against P50 of NF-κB. As shown in Figure
4B, the addition of this antibody resulted in a supershifted
complex in addition to the DNA-protein band. These data
confirm the presence of the NF-κB family member, P50,
in the nuclear protein complex that binds the NF-κB bind-
ing site of the CS-1 promoter.
The inhibition of NF-κB downregulates CS-1 promoter 
activity but does not affect CS-2
To further illustrate the biological importance of NF-κB in
the regulation of CS-1, we inhibited NF-κB transactivation
by treatment with pyrrolidine dithiocarbamate (PDTC), a
proven free radical scavenger that accelerates IκB dissocia-
tion with a resulting block in NF-κB transport to the
nucleus and subsequent binding to DNA. As shown in
Figure 5, when C2C12 cells were transfected with the 2.5-
kb wild type CS-1 and CS-2 promoter luciferase reporter
plasmids, a 20-fold and 16-fold increase in reporter activ-
ity was observed, respectively. The treatment of these cells
with PDTC induces a modest decrease in luciferase activity
for both wild-type reporter plasmids, and had no impact
on the empty vector control (Fig. 5). Transfection of the
shorter  CS-1  and  CS-2  promoter fragment reporters
(pCS1-427/-144 and pCS2-561/-67), both containing
their respective putative NF-κB elements, results in a 25-
fold and 10-fold increase in luciferase activity, respec-
tively. In this same experiment, PDTC treatment induced
a 2–3-fold decrease in luciferase activity for CS-1 but no
apparent changes were evident for the CS-2 reporter activ-
ities. However, when cells were transfected with the CS-1
and CS-2 reporter plasmids containing proximally shorter
promoter fragments (pCS1-337/-144 and pCS2-482/-67),
we again detected a large increase in luciferase activity
compared with the empty vector, but PDTC has no effects.
These data suggest that the NF-κB binding element
located in the region -427 to -337 of CS-1 promoter plays
an important role in the transcriptional activity of this
gene.
The effects of NF-κB, NFAT and MEF2 overexpression 
upon the CS-1 and CS-2 promoters
Since putative NFAT and MEF2 binding elements are
located within the CS-1 and CS-2 promoters, the sensitiv-
ities of the NFAT and MEF2 sites, as well as NF-κB site, to
the overexpression of specific transcription factors were
also determined. First, the 2.5-kb wild type CS-1 and CS-
2 promoters were cotransfected with pReceiver-NF-κB1,
which constitutively expresses the NF-κB subunit gene
p50. The overexpression of p50 significantly induces CS-1
promoter activity and also the positive NF-κB reporter
control (pNF-κB-Luc). A further 5' deletion of the NF-κB
site totally abolishes the response to NF-κB overexpres-
sion, reconfirming the authenticity of this site. However,
the activity of CS-2 promoter was found to be increased by
1.7-fold when cotransfected with NF-κB in these experi-
ments, indicating that CS-2 is not independent of NF-κB.
This partially contradicts the results of our gel shift and
drug treatment experiments. Hence, other NF-κB ele-
ments may exist in the CS-2 promoter or it may be trig-
gered by other factors induced by NF-κB.
As a preliminary test for the role of the calcineurin-NFAT-
MEF2 signalling pathway [8] in the regulation of the cal-
sarcin promoters, we next determined whether the CS-1 or
CS-2  promoters are sensitive to the overexpression of
NFAT or MEF2 in C2C12 cells. When cotransfected with
the NFATc4 expression plasmid (pcDNA-NFATc4), both
of the promoters show enhanced transcription activities,
but to different extents (CS-1, 7.2 ± 2.3 fold; CS-2, 4.4 ±
1.8 fold; and pNFAT-Luc, 68.8 ± 13.6 fold). However,
only a moderate decrease in promoter activity was
observed after 5' deletion of the -1206 to -926 region of
CS-1  promoter which harbours a NFAT consensus ele-
ment, indicating that other putative binding motifs are
present. Similarly, MEF2C overexpression was achieved
by cotransfection of pReceiver-MEF2C with the luciferase
reporter vector. This overexpression induces the activity of
the  CS-1  promoter by 3.5-fold but has only marginal
effects upon the CS-2 promoter. This indicates that MEF2
also contributes to the differential transcription of the cal-
sarcins in different fibres. However, it is noteworthy that
both promoters contain several putative MEF2 binding
elements (Fig. 6).
Discussion
The differences in the contractile and biochemical proper-
ties of slow- and fast-twitch myofibres are determined by
the selective transcription of genes coding for contractile
proteins and metabolic enzymes in these muscles. These
distinctive programs of gene expression are further con-BMC Molecular Biology 2007, 8:19 http://www.biomedcentral.com/1471-2199/8/19
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EMSA analysis of the NF-κB binding sites in the mouse CS-1 and CS-2 promoters Figure 4
EMSA analysis of the NF-κB binding sites in the mouse CS-1 and CS-2 promoters. A. 32P labelled oligonucleotide 
probes for the NF-κB consensus, NF-κB CS-1 and NF-κB CS-2 binding sites were incubated with C2C12 myotube nuclear 
extracts. B. Competition experiments were performed using a 100-fold excess of unlabeled NF-κB consensus and NF-κB CS-1 
probes. Supershift assays were performed with anti-P50 antibody. Arrows indicate the resulting bandshifts.BMC Molecular Biology 2007, 8:19 http://www.biomedcentral.com/1471-2199/8/19
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trolled by various regulatory elements and pathways, such
as the calcineurin signalling pathway, which still require
further elucidation. One approach to further understand-
ing the molecular mechanisms controlling muscle diversi-
fication and plasticity is to identify the DNA regulatory
sequences that control the fibre-type-specific expression
of contractile protein genes. The study of the transcrip-
tional regulation of fibre-type-specific calsarcins, which is
also a family of calcineurin-interaction proteins, would
contribute to our understanding of the role of calcineurin
in muscle fibre differentiation.
In our present study, we determined by RT-PCR that the
transcription start sites of the mouse CS-1 and CS-2 genes
are in the regions -191 to -176 and -82 to -74 upstream of
the ATG initiation codon, respectively. We then isolated
the promoter regions of these mouse calsarcin genes by
PCR. In order to identify their cis-regulatory elements, a
series of deletion constructs from the 5'-flanking regions
were analyzed. For CS-1, we found that a construct con-
taining a putative NF-κB site demonstrated the highest
promoter activity levels. We thus speculated that this
potential binding site for NF-κB and other putative tran-
scription factor sites in this region would be important for
the expression of the CS-1 gene. A significant decrease in
CS-1 promoter reporter activity was indeed observed after
the further deletion of this NF-κB element. It is thus quite
likely that the NF-κB site in the CS-1 promoter contributes
greatly to its transactivation. However, a putative NF-κB
site is also located in the core region of CS-2 promoter, but
our deletion reporter analysis did not reveal any signifi-
cant involvement of this element in the transcriptional
control of CS-2.
Gel retardation assays were performed to validate the
binding of NF-κB to the core promoter regions of CS-1
and CS-2. A CS-1 NF-κB sequence probe was found to
induce a bandshift when incubated with nuclear extracts
from C2C12 myotubes in a similar manner to the NF-κB
consensus sequence control. However, no such band was
evident when these extracts were incubated with a CS-2
NF-κB sequence. Competition and supershift EMSA
experiments further confirmed that the NF-κB element in
the core region of the CS-1 promoter is recognized by the
P50 subunit of NF-κB. Moreover, treatment with an NF-
κB inhibitor (PDTC) resulted in a dramatic reduction in
reporter gene activity of the deletion fragment pCS1-427/
-144, which harbours the NF-κB binding element, with a
modest decrease evident in the activity of the wild-type
CS-1 promoter in this experiment. In contrast, none of the
additional reporter constructs showed any PDTC respon-
siveness. In addition, the region located upstream of the
NF-κB element in the CS-1 promoter appears to contain
suppressive elements that reduce the effects of this inhib-
itor. Overexpression of p50 of NF-κB increases the activity
of the CS-1 promoter significantly, but no real change was
evident for CS-2 in this analysis. Taken together, these
data suggest that NF-κB plays a critical role in the tran-
scriptional activity of the mouse CS-1 gene, but does not
play the same role for CS-2.
Several studies have previously demonstrated that cal-
cineurin stimulates slow muscle gene promoters and slow
fibre differentiation, both in culture and in vivo, via the
calcineurin-NFAT signalling pathway [11-13]. This mech-
anism has also been found to be active for many type-spe-
cific genes harbouring a SURE element (containing the
NFAT sequence) in the slow promoter, and a FIRE ele-
ment in the fast promoter [8,14,15]. However, no effects
of calcineurin on slow muscle gene expression have been
observed in other studies based either on CsA treatment
[16] or on the overexpression of calcineurin and NFAT
[17]. In our present study, sequencing analyses did not
reveal any consensus SURE or FIRE elements within the
CS-1 and CS-2 gene promoters, but putative NFAT bind-
ing sites were evident in both of these promoters by TESS
analysis. To determine whether NFAT or MEF2 are
involved in the transcription regulation of these genes, we
overexpressed NFATc4 and MEF2C and compared the
resulting the promoter activities with their corresponding
basal levels. The CS-1 promoter was found to be upregu-
The differential effects of PDTC on the activity of mouse CS1  and CS2 gene promoter fragments harbouring 5' deletions Figure 5
The differential effects of PDTC on the activity of 
mouse CS1 and CS2 gene promoter fragments har-
bouring 5' deletions. At 24 hours after transfection with 
reporter constructs, C2C12 cells were treated with PDTC 
(10 μM) for a further 24 hours, and the firefly luciferase 
activities were measured and normalized to the Renilla luci-
ferase controls. The data values are the fold-increases (mean 
± SD) in luciferase activity for each treatment over the basic 
luciferase vector sample activity without PDTC, and are the 
results of triplicate experiments. The statistical significance of 
the differences between the basal transcription and PDTC 
exposure values were analyzed by the Student's t-test, * P < 
0.05, ** P < 0.001.BMC Molecular Biology 2007, 8:19 http://www.biomedcentral.com/1471-2199/8/19
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lated by either NFATc4 or MEF2C, whereas CS-2 appears
to be more resistant to this activation, indicating that
these factors may also play a role in the transcriptional
control of these genes. These findings also raised the pos-
sibility that calcineurin-NFAT signalling pathway partici-
pates, at least partly, in the regulation of the calsarcin
promoters. It is thought that no single regulatory pathway
can dominate the regulation of each muscle-specific gene
[18], and it is considered likely that different pathways act
cooperatively in the exclusive expression of a specific gene
in slow or fast fibres. Interestingly, an important signal-
ling and functional link between the calcineurin-NFAT
and calcineurin-NF-κB pathways has been established by
stable expression of constitutively active calcineurin in
muscle C2C12 cells. This proposed model suggests dual
actions for calcineurin upon terminal differentiation with
opposing phenotypes, through its transient effects on
NFAT and prolonged effects on NF-κB, respectively [19].
Studies of CS-1 knockout mice also demonstrate that CS-
1 negatively modulates the functions of calcineurin and it
will therefore be important to determine whether the tran-
scription of the calsarcins is also subject to regulation by
calcineurin signalling.
NF-κB has been implicated as a modulator of muscle
catabolism and as a putative regulator of protein break-
down from existing fibres [20]. However, the complexities
of the NF-κB signalling mechanisms in muscle are just
now beginning to be elucidated. Significantly also, disuse
muscle atrophy is associated with the activation of the NF-
κB pathway [21,22], and disruption of the NF-κB1 gene
inhibits skeletal muscle atrophy mainly in fast fibres [23].
The slow fibres in this case are atrophied to the same
extent as their normal counterparts, indicating that there
are different roles for NF-κB1 in slow and fast fibres dur-
ing muscle atrophy [23]. In our current study, we have
shown that the slow fibre specific CS-1, but not fast fibre
specific CS-2, is a putative downstream target gene of NF-
κB. Other factors related to calcineurin, such as NFAT and
MEF2, were also found to participated in the regulation of
these two gene promoters. In other words, the activation
of this fibre-specific transcription appears to be mediated
The activation of CS-1 and CS-2 promoters by different signalling molecules Figure 6
The activation of CS-1 and CS-2 promoters by different signalling molecules. A. Deleted promoter constructs of 
CS-1 and CS-2 were used in the NF-κB p50 cotransfection analysis. A schematic representation of these two promoters is 
shown. These vectors were cotransfected with pReceiver-NF-κB1. B. A range of different truncated promoter constructs 
(pCS1-2554/-144, pCS1-926/-144 and pCS2-2478/-67) were cotransfected with pcDNA-NFATc4. A consensus NFAT element 
in the region -1206 to -926 was removed in the pCS1-926/-144 vector. C. The two wild type calsarcin promoters were 
cotransfected with pReceiver-MEF2C. The pNF-κB-Luc, pNFAT-Luc and pMEF2-Luc vectors were used as controls. Values are 
expressed as ratios of the basal activity (resulting from cotransfection with an empty pcDNA3.1 vector) and represent the 
mean ± SD for two sets of independent experiments, each performed in triplicate. (Note: comparison of luciferase activity 
between different vectors is not valid.)BMC Molecular Biology 2007, 8:19 http://www.biomedcentral.com/1471-2199/8/19
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by a combinatorial mechanism involving different path-
ways and multiple factors. However, this mechanism was
only tested in C2C12 myotubes in our present study, and
whether further investigations will be needed in vivo. In
addition, as it has also been speculated that the overex-
pression of a specific signalling factor may impact upon
multiple muscle genes rather than just one targeted gene,
we cannot yet exclude the possibility that the induced pro-
moter activity is non-specific or is due to system effects of
the enhanced pathways which were analysed. Hence,
whether this selective transactivation of calsarcins by NF-
κB as well as other factors contributes to the atrophy dis-
crepancies or the opposing phenotypes seen in slow and
fast fibres needs further study.
Conclusion
Our current results provide the first insights into the
mechanisms regulating the transcription of members of
the mouse calsarcin gene family, which are differentially
expressed in slow- or fast-twitch muscle fibre cells. We
have defined the proximal promoter region of both the
CS-1  and  CS-2  genes and further identified an NF-κB
binding site in CS-1 core region, which contributes signif-
icantly to the transcriptional control of this gene. Addi-
tionally, our data reveal that NF-κB has effects upon CS-1,
but not CS-2, promoter function. In addition, the results
of our overexpression analysis suggest that NFAT and
MEF2 are also involved in the transcriptional regulation
of these two genes. Our data thus suggest that NF-κB plays
an important role in the regulation of calsarcin expression
and that different signalling pathways may cooperate with
each other in a complex network of calsarcin transcrip-
tional regulation. These findings provide some important
clues that will enable further analysis of the role of cal-
sarcin gene family in fibre-type specificity via calcineurin
signalling.
Methods
Cell culture
C2C12 mouse skeletal myoblasts were cultured in
DMEM/high glucose supplemented with 20% FBS, 100
units/ml penicillin and 100 μg/ml streptomycin and
maintained at 37°C in 5% CO2. The differentiation of
C2C12 myoblasts into myotubes was achieved by the
addition of differentiation medium (DMEM supple-
mented with 2% horse serum) for up to 6 days with
medium changes every 2 days.
RT-PCR and real-time PCR
C2C12 cells were cultured in six-well plates and harvested
for RNA extraction according to the time course of differ-
entiation. Total RNA was isolated using Trizol reagent
(Invitrogen) according to the manufacturer's instructions.
cDNA was then reverse-transcribed from normalized RNA
using random hexamer primers and M-MLV reverse tran-
scriptase (Promega). To identify the initial transcription
start site of the CS-1 and CS-2 genes, primer sets were
designed for use with an RT-PCR kit (TaKaRa), according
to the manufacturer's instructions [see Additional file 1].
Real-time PCR was performed using the SYBR Premix Ex
Taq Kit (TaKaRa) with cycling conditions consisting of an
initial 5 min at 95°C, followed by 35 cycles comprising 15
sec at 95°C, 20 sec at 61°C, 20 sec at 72°C, and fluores-
cence acquisition at 83°C for 1 sec. Purified T-easy vectors
(Promega) containing the target promoter fragments were
serially diluted (undiluted, 1/4, 1/16, 1/64 and 1/256) to
construct standard curves for determining the optimal
amplification conditions. PCR was then performed in
triplicate and the gene expression levels were quantified
relative to the expression of β-actin using Gene Expression
Macro software (Bio-Rad), employing an optimized com-
parative Ct (ΔΔCt) value method. Dissociation curves
were generated to ensure a single amplicon had been pro-
duced.
Plasmid constructs
The mouse CS-1 and CS-2 gene sequences were obtained
from GenBank (NC_000069 and NC_000080) and were
employed to designed primers that would isolate their 5'-
flanking regions. For this purpose, we utilized LA Taq
(TaKaRa), and cloned the amplicons into the T-Easy vec-
tor for subsequent manipulation. A series of constructs
containing variable lengths of the mouse CS-1 and CS-2
promoter was then generated by PCR using forward prim-
ers for sequences located at varying distances from the
major transcription start site and including an MluI recog-
nition sequence to facilitate ligation. The primers pCS1-
144R and pCS2-67R, both containing a XhoI recognition
sequence, were used as the common reverse primer for
their respective genes and had 5' ends which were located
within the first exon in each case [see Additional file 1].
Amplified fragments were then inserted into the multiple
cloning site of the pGL3-basic vector to generate luciferase
reporter constructs. The NFkB1 and MEF2C overexpres-
sion vectors were pReceiver-NF-κB1 and pReceiver-
MEF2C, encoding p50 and MEF2C (GeneCopoeia). The
coding region of NFATc4 gene was cloned into the XbaI-
BamHI site of pcDNA3.1 to construct the NFAT expression
vector pcDNA-NFATc4. The pNF-κB-Luc and pNFAT-Luc
reporter plasmids were purchased from Stratagene. The
pMEF2-Luc reporter construct contains three tandem cop-
ies of the consensus binding element (GGCTCTAAAAAT-
AGCCCCC) upstream of the basic promoter element
(TATA box) and the luciferase gene.
Transfections and drug treatments
The cells were seeded into 96-well plates at an initial den-
sity of 60–80% and cultured overnight to ensure adhesion
and spreading. Co-transfections were then performed
using 0.5 μl of Lipofectamine 2000 reagent (Invitrogen)BMC Molecular Biology 2007, 8:19 http://www.biomedcentral.com/1471-2199/8/19
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with 200 ng of the appropriate firefly luciferase plasmid
DNA, and 20 ng of pRL-TK plasmid DNA (Promega) as an
internal control. For cotransfection analyses, the levels of
reporter plasmids were kept constant, but 100 ng of the
relevant expression vector or empty pcDNA3.1 were
added. The pGL3-Control vector (Promega) was used as a
positive control. The transfection medium was removed
and replaced with growth medium after 4 to 6 hours. The
differentiation medium was then added 12 hours after
transfection. Firefly and Renilla luciferase activities were
measured at 48 hours post-transfection using the Dual-
Glo Luciferase assay system (Promega) and a TD20/20
luminometer (Turner Designs). The transfection efficien-
cies in each case were normalized using the Renilla luci-
ferase activity levels and each construct was tested in
triplicate in a minimum of three independent experi-
ments. At 24 hours after transfection, the cells were treated
with 10 μM PDTC (pyrrolidine dithiocarbamate, Sigma,
St. Louis, MO) and cultured for another 24 hours before
assaying for luciferase activity.
Gel Mobility Shift Assay
Nuclear extracts were prepared from cultured C2C12
myotubes using the NE-PER Nuclear and Cytoplasmic
Extraction kit (Pierce). The protein concentrations were
determined using the Bradford assay (Bio Rad). Nuclear
protein extracts (3–6 μg) were then incubated in 10 μl of
binding buffer (10 mM Tris-HCl, pH 7.5, 4% glycerol, 1
mM MgCl2, 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl, 50
μg/ml of double-stranded poly [dI-dC]) at room tempera-
ture for 10 min before adding 35 fmol of the appropriate
end-labelled double-stranded oligonucleotide [see Addi-
tional file 1]. DNA labelling was performed using T4 poly-
nucleotide kinase and [γ-32P] ATP. Formation of the
DNA-protein complexes was allowed to proceed for 20
min at room temperature before stopping the reaction by
the addition of 1 μl gel loading dye. For competition
experiments, a 100-fold excess of unlabeled double-
stranded oligonucleotide was added to the reaction. For
supershift experiments, 2 μg of antibody against P50 of
NF-kappaB (Santa Cruz Biotechnology, Santa Cruz) was
added to the reaction mixture and incubated with the
nuclear extracts on ice for 15 min before the addition of
the probe, followed by a further incubation on ice for 20
min. The samples were then electrophoresed on 4% non-
denaturing polyacrylamide gels in 0.5 × TBE buffer (45
mM Tris, 45 mM borate, 1 mM EDTA, pH 8.3) and the gels
were dried and exposed to X-ray film at -70°C with inten-
sifying screens.
DNA sequence analysis
DNA sequences were analyzed for the presence of putative
transcription factor binding sites using the TESS (Tran-
scription Element Search System) web tool available from
the Computational Biology and Informatics Laboratory at
the University of Pennsylvania.
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